![David Thurston](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Thurston
Founder at Pheon Therapeutics Ltd.
Network origin in David Thurston first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pheon Therapeutics Ltd.
![]() Pheon Therapeutics Ltd. BiotechnologyHealth Technology Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023.
11
| Holding Company | Biotechnology | 11 |
ADC Products (UK) Ltd.
![]() ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom.
5
| Subsidiary | Medical/Nursing Services | 5 |
Transcriptogen Ltd.
![]() Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David Thurston via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Officer/Principal | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
![]() Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Imperial College London | College/University | Masters Business Admin | |
RCT BioVentures
![]() RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Investment Managers | Chief Executive Officer | |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Private Equity Analyst | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Corporate Officer/Principal Masters Business Admin | |
Indiana University | College/University | Undergraduate Degree | |
Georgetown University | College/University | Graduate Degree | |
American Cancer Society, Inc.
![]() American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Beth Israel Deaconess Medical Center, Inc.
![]() Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Director/Board Member | |
Glaxo, Inc. | Corporate Officer/Principal | ||
DIUL GROUP | Pharmaceuticals: Major | Chairman | |
Glaxo Laboratories Ltd.
![]() Glaxo Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK. | Medical Distributors | Corporate Officer/Principal | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman | |
SPERO THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Harvard College | College/University | Undergraduate Degree | |
Solent NHS Trust
![]() Solent NHS Trust Investment Trusts/Mutual FundsMiscellaneous Solent NHS Trust provides trust services. The non-profit company is based in Millbrook, UK. Sue Harriman has been the CEO of the British company since 2014. | Investment Trusts/Mutual Funds | Chairman | |
Padlock Therapeutics, Inc.
![]() Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
SURFACE ONCOLOGY, INC. | Biotechnology | Chief Operating Officer | |
AVROBIO, INC. | Biotechnology | Director/Board Member | |
IFM Therapeutics LLC
![]() IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
ARIX BIOSCIENCE PLC | Investment Managers | Chief Executive Officer | |
Artios Pharma Ltd.
![]() Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Indalo Therapeutics, Inc.
![]() Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Depixus SAS
![]() Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Autism Research Trust
![]() Autism Research Trust Medical/Nursing ServicesHealth Services Autism Research Trust provides health care services. The private company is based in Leeds, UK. The CEO of the British company is Marie Davies. | Medical/Nursing Services | Director/Board Member | |
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
STipe Therapeutics ApS
![]() STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member | |
DOT Therapeutics-2, Inc.
![]() DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Versanis Bio, Inc.
![]() Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Biotechnology | Director/Board Member | |
THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
MOMA Therapeutics, Inc.
![]() MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Xilio Therapeutics LLC
![]() Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 32 |
United Kingdom | 12 |
France | 4 |
Israel | 3 |
Canada | 2 |
Sectoral
Health Technology | 31 |
Finance | 6 |
Commercial Services | 6 |
Consumer Services | 6 |
Health Services | 3 |
Operational
Director/Board Member | 74 |
Corporate Officer/Principal | 38 |
Chief Executive Officer | 14 |
Founder | 14 |
Chairman | 13 |
Most connected contacts
- Stock Market
- Insiders
- David Thurston
- Company connections